RAD vs RNV

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

RAD

RADIOPHARM FPO [RAD]

40LOW

RNV

RENERVE FPO [RNV]

38LOW

Score Breakdown

RAD RNV
Technical
55
61
Catalyst
53
53
Sentiment
50
50
Fundamental
76
54
Momentum
45
48
Risk Gate
37
40

Key Metrics

RAD Metric RNV
$47.3MMarket Cap$13.8M
4.5MAvg Volume (20d)66K
+0.0%Short InterestN/A
$0.04052-Week High$0.220
$0.01752-Week Low$0.069
+0.0%Daily Change+0.0%
$0.020Reference Price$0.080
-92.1%ROE-74.9%
-286.2%Profit MarginN/A

Active Signals

RAD Signals

●MACD momentum is picking up steam
●Above-average volume (1.5x) on a green day — buyers stepping up
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Low P/S ratio (2.9x)
●Strong revenue growth (+154%)
●EPS estimates revised upward (+10pts)

RNV Signals

●MACD momentum is picking up steam
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Strong revenue growth (+60%)
●Near 52-week low (7% of range)
●Micro-cap ($5-20M) - high risk

Ask Scout AI to compare RAD and RNV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

RAD vs SHG →RCE vs SLD →RCE vs SNT →REG vs RNV →REG vs SHG →
RAD Full Analysis → RNV Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).